Skip to content
PubMed This is a summary of 9 peer-reviewed journal articles Updated
Dermatology

Understanding Your IgA Pemphigus Diagnosis

At a Glance

IgA pemphigus is a rare, noncontagious autoimmune skin disease that causes itchy, sterile pustules or vesicles. It often follows a relapsing course, but treatments such as dapsone or corticosteroids can help control flares.

Important Note: This guide is designed to help you understand your diagnosis and communicate effectively with your medical team. It does not replace an individualized dermatologist’s assessment. Never start, stop, or alter your doses of dapsone or systemic steroids without speaking to your prescriber.

Receiving a diagnosis of IgA Pemphigus often comes after a long, confusing, and emotionally taxing journey. If you spent months or even years visiting different doctors and trying various creams for what looked like an infection, only to have it persist, your experience is common for this condition [1]. Because this disease is so rare, many healthcare providers have never seen a case in person, leading to an average diagnostic delay of nearly 10 months—and for some, it can take over a decade to find the right answer [1].

What is IgA Pemphigus?

IgA Pemphigus is an autoimmune condition, which means your immune system—specifically a type of antibody called IgA—is mistakenly attacking your own skin cells [2]. In a healthy body, IgA antibodies usually protect your mucous membranes (like your mouth and gut). In this condition, they target the “glue” that holds your skin cells together [3].

When this glue is attacked, your skin cells separate, creating space for fluid and inflammatory cells to rush in. This results in the characteristic small, fluid-filled bumps called pustules (filled with white blood cells) or vesicles (filled with clear fluid) [2].

Why Your Doctor May Be Unfamiliar

This condition is exceptionally rare. In large medical studies, IgA Pemphigus accounts for only about 1% to 2.4% of all pemphigus cases [4][5]. To put that in perspective, the more common versions (like Pemphigus Vulgaris) are seen up to 50 times more frequently [6]. Because it is so unusual, it is often helpful to have your care managed or co-managed by a specialist at a major academic hospital who has specific expertise in autoimmune blistering diseases.

Clearing Up Common Misunderstandings

One of the most frustrating parts of living with IgA Pemphigus is the appearance of the skin. The white or yellow bumps often look exactly like a bacterial infection or a contagious “staph” rash.

  • It is not an infection: The pustules in IgA Pemphigus are usually sterile, meaning they are filled with your own white blood cells (neutrophils) rather than bacteria or viruses [7].
  • It is not contagious: You cannot “catch” this from anyone, and you cannot spread it to others through touch or close contact [7].
  • It is not your fault: Autoimmune diseases are not caused by hygiene or lifestyle choices; they are a result of the immune system misfiring.

How It Differs from Other Pemphigus Types

While most forms of pemphigus involve an antibody called IgG, your condition involves IgA. This difference changes how the disease behaves:

  • The Mechanism: IgG-type pemphigus usually works by directly interfering with the “glue” molecules. IgA-type pemphigus is unique because it often recruits white blood cells to the site, which is why your rash looks “pustular” (filled with white fluid) rather than just clear blisters [3][8].
  • The Sensation: IgA Pemphigus is frequently associated with intense pruritus (itching), which is reported by many patients [2].

What to Expect Long-Term

IgA Pemphigus is typically a chronic relapsing condition [9]. This means there will likely be periods where your skin is clear (remission) and times when the rash reappears (flares).

While there is currently no “permanent cure,” the condition is generally manageable with medications like dapsone or corticosteroids, which help calm the immune response [2]. Your doctor will develop a treatment plan tailored to the diagnosis. Your medical team will monitor you closely, as IgA Pemphigus can sometimes be associated with other internal conditions, such as inflammatory bowel disease or specific blood protein changes [2]. With the right diagnosis finally in hand, you and your doctor can focus on a targeted plan to bring your immune system back into balance.

Common questions in this guide

What is IgA pemphigus, and is it contagious?
IgA pemphigus is a rare autoimmune skin condition in which IgA antibodies mistakenly target the connections between skin cells, causing pustules or vesicles. It is not an infection and is not contagious.
Why can IgA pemphigus be mistaken for a bacterial rash?
The white or yellow bumps can resemble a staph or other bacterial infection, but the pustules are usually sterile and contain immune cells rather than bacteria. This resemblance can contribute to a delayed diagnosis.
How do doctors confirm an IgA pemphigus diagnosis?
A dermatologist uses your skin findings and biopsy results to support the diagnosis and may determine which subtype you have. Because the disease is rare, consultation with a clinician experienced in autoimmune blistering diseases can be helpful.
What treatments are commonly used for IgA pemphigus?
Doctors may use dapsone or systemic corticosteroids to calm the abnormal immune response. The choice and dose should be individualized and monitored by your prescriber, so do not start, stop, or change these medicines on your own.
Does IgA pemphigus go away permanently?
IgA pemphigus is usually chronic and relapsing, with periods of remission and flares. There is no permanent cure currently, but treatment can help control the rash and support longer clear periods.
Do sterile pustules mean antibiotics are never needed?
The pustules caused by IgA pemphigus are usually sterile, so antibiotics do not treat the underlying autoimmune condition. A separate bacterial infection can still develop in affected skin, so ask your clinician how to watch for signs of secondary infection.
Could IgA pemphigus be associated with other health problems?
IgA pemphigus can sometimes occur alongside inflammatory bowel disease or certain changes in blood proteins. Your dermatologist can decide whether your symptoms and laboratory results warrant additional evaluation or referral.

Get notified when new evidence is published on IgA pemphigus.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (9)
  1. 1

    A 14-year multicentric follow-up study of atypical pemphigus variants in Italy: the VARIANT_P study.

    Quintarelli L, Bonanni I, Mariotti EB, et al.

    Clinical and experimental dermatology 2026; (51(2)):250-262 doi:10.1093/ced/llaf438.

    PMID: 41072932
  2. 2

    IgA pemphigus: A systematic review.

    Kridin K, Patel PM, Jones VA, et al.

    Journal of the American Academy of Dermatology 2020; (82(6)):1386-1392 doi:10.1016/j.jaad.2019.11.059.

    PMID: 31812619
  3. 3

    Pathogenic Activation and Therapeutic Blockage of FcαR-Expressing Polymorphonuclear Leukocytes in IgA Pemphigus.

    Emtenani S, Ghorbanalipoor S, Mayer-Hain S, et al.

    The Journal of investigative dermatology 2021; (141(12)):2820-2828 doi:10.1016/j.jid.2021.06.007.

    PMID: 34246620
  4. 4

    Clinical Patterns, Survival, Comorbidities, and Treatment Regimens in 149 Patients With Pemphigus in Tuscany (Italy): A 12-Year Hospital-Based Study.

    Quintarelli L, Coi A, Maglie R, et al.

    Frontiers in immunology 2022; (13()):895490 doi:10.3389/fimmu.2022.895490.

    PMID: 35880183
  5. 5

    The epidemiology of autoimmune bullous diseases in Sudan between 2000 and 2016.

    Siddig O, Mustafa MB, Kordofani Y, et al.

    PloS one 2021; (16(7)):e0254634 doi:10.1371/journal.pone.0254634.

    PMID: 34255799
  6. 6

    A Clinicopathological Study of Pemphigus in Eastern India with Special Reference to Direct Immunofluorescence.

    Chowdhury J, Datta PK, Chowdhury SN, Das NK

    Indian journal of dermatology 2016; (61(3)):288-94 doi:10.4103/0019-5154.182422.

    PMID: 27293249
  7. 7

    Superficial and Bullous Neutrophilic Dermatoses: Sneddon-Wilkinson, IgA Pemphigus, and Bullous Lupus.

    Manjaly P, Sanchez K, Gregoire S, et al.

    Dermatologic clinics 2024; (42(2)):307-315 doi:10.1016/j.det.2023.08.010.

    PMID: 38423689
  8. 8

    Subcorneal pustular dermatosis-type IgA pemphigus associated with multiple myeloma: A case report and literature review.

    Koga H, Tsutsumi M, Teye K, et al.

    The Journal of dermatology 2023; (50(2)):234-238 doi:10.1111/1346-8138.16516.

    PMID: 35838241
  9. 9

    Case Report: A rare co-occurrence of IgA pemphigus and pyoderma gangrenosum associated with IgA-κ type monoclonal gammopathy of undetermined significance: a 19-year diagnostic and therapeutic journey.

    Xie Y, Liu X, Wu J, et al.

    Frontiers in immunology 2026; (17()):1832860 doi:10.3389/fimmu.2026.1832860.

    PMID: 42245644

This page is for informational purposes only and does not constitute medical advice or replace an individualized dermatologist’s assessment. Do not start, stop, or change dapsone or steroid doses without speaking with your prescriber.